Pascal Colosetti
Impact in
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- TGF-β signaling in diseases
- Cell death mechanisms and regulation
- Extracellular vesicles in disease
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 8
-
- Extracellular vesicles in disease 5
- Cell death mechanisms and regulation 5
- TGF-β signaling in diseases 4
- Co-authors
- Patrick Auberger (24 shared papers)Kohei Miyazono (5 shared papers)Carl‐Henrik Heldin (3 shared papers)Arnaud Jacquel (14 shared papers)Frédéric Luciano (9 shared papers)Frédéric Bost (2 shared papers)Issam Ben Sahra (2 shared papers)Magali Herrant (3 shared papers)
- Journals
- Oncogene (7 papers)Leukemia (6 papers)Autophagy (3 papers)BioMed Research International (2 papers)PLoS ONE (2 papers)
- Partner nations
- FranceSwedenUnited States
In The Last Decade
Pascal Colosetti
55 papers receiving 3.7k citations
Pascal Colosetti's Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 2k
- Hematology 338
- Cancer Research 211
- Drug Discovery 4
- Sensory Systems 70
Countries citing papers authored by Pascal Colosetti
This map shows the geographic impact of Pascal Colosetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Colosetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Colosetti more than expected).
Fields of papers citing papers by Pascal Colosetti
This network shows the impact of papers produced by Pascal Colosetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Colosetti. The network helps show where Pascal Colosetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Colosetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Hit paper breakdown → | 2008 | 764 |
| 2 | 1991 | 448 | |
| 3 | 2003 | 417 | |
| 4 | 1992 | 166 | |
| 5 | 2004 | 154 | |
| 6 | 2020 | 136 | |
| 7 | 2015 | 113 | |
| 8 | 2015 | 107 | |
| 9 | 2009 | 83 | |
| 10 | 2009 | 74 | |
| 11 | 1997 | 73 | |
| 12 | 2005 | 72 | |
| 13 | 2009 | 69 | |
| 14 | 2004 | 66 | |
| 15 | 2008 | 60 | |
| 16 | 2014 | 56 | |
| 17 | 2015 | 55 | |
| 18 | 1999 | 49 | |
| 19 | 2012 | 49 | |
| 20 | 2014 | 44 |
About Pascal Colosetti
Pascal Colosetti is a scholar working on Hematology, Molecular Biology, Sensory Systems, Epidemiology and Oncology, having authored 55 papers that have together received 3.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Autophagy in Disease and Therapy (7 papers), Organ Transplantation Techniques and Outcomes (5 papers), Extracellular vesicles in disease (5 papers), Cell death mechanisms and regulation (5 papers), TGF-β signaling in diseases (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Ion Channels and Receptors (3 papers). The work is most often cited by research in Molecular Biology (2k citations), Hematology (338 citations), Cancer Research (211 citations), Drug Discovery (4 citations) and Sensory Systems (70 citations). Pascal Colosetti has collaborated with scholars based in France, Sweden and United States. Frequent co-authors include Patrick Auberger, Kohei Miyazono, Carl‐Henrik Heldin, Arnaud Jacquel, Frédéric Luciano, Frédéric Bost, Issam Ben Sahra, Magali Herrant, Jean‐François Tanti and Yannick LE MARCHAND‐BRUSTEL. Their work appears in journals such as Oncogene, Leukemia, Autophagy, BioMed Research International and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.